Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Gluroo is an app for managing diabetes and prediabetes. Its core goal is to bring day-to-day management data—such as blood glucose, meals, and exercise—into one place, reducing the burden of logging and checking information. It is designed not only for patients themselves, but also emphasizes support for “someone else,” meaning family members or caregivers can keep track of health data together.
Based on the captured text, Gluroo’s key capabilities include centralized viewing of blood glucose, meals, and exercise, as well as linking glucose readings with events logged by the user. It claims to integrate with multiple CGM devices and pumps, allowing users and their friends or family to view and share data. Gluroo also supports displaying glucose values on watches, phone lock screens, widgets, and Live Activities, which can be valuable for users who need to monitor glucose changes frequently. The text also mentions Meal Logging, but does not go into detail about nutrition analysis, carb counting, or reminder features.
The currently captured content does not disclose plans, pricing, free-tier or trial information, nor does it mention supported payment methods. For collaboration, we can only confirm that it supports sharing data with loved ones; there is no visible detail on role-based permissions, family member management, care-team collaboration, or audit logs. For a health-data product, data security, privacy protection, and medical compliance are critical. However, the text does not provide information on HIPAA, GDPR, encryption, data storage regions, or similar topics, so enterprises or healthcare organizations should verify these points further before adoption.
Its strengths are a focused use case and straightforward functionality. It is suitable for people with diabetes who want to view CGM/pump data, meal logs, and exercise records in one place, as well as for family members who want to monitor data remotely. Multi-device display of glucose values improves daily visibility and usability. The main drawback is that public information is incomplete: specific compatible devices, pricing, security compliance, API availability, and deployment options are not listed, making it difficult to assess its controllability in healthcare-provider or enterprise scenarios.
Access from China cannot be determined from the text, and payment methods and local compliance are also not disclosed. If using it in China, key points to verify include app availability, device compatibility, network connectivity, notification reliability, and cross-border data issues. Alternatives may include official apps from CGM manufacturers, local blood-glucose management tools, or health-management platforms with Chinese-language support and local services.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on gluroo.com official site.
gluroo.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach gluroo.com directly.